JP2014506671A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014506671A5 JP2014506671A5 JP2013552696A JP2013552696A JP2014506671A5 JP 2014506671 A5 JP2014506671 A5 JP 2014506671A5 JP 2013552696 A JP2013552696 A JP 2013552696A JP 2013552696 A JP2013552696 A JP 2013552696A JP 2014506671 A5 JP2014506671 A5 JP 2014506671A5
- Authority
- JP
- Japan
- Prior art keywords
- branched polymer
- molecules
- molecule
- biological material
- conjugated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920000642 polymer Polymers 0.000 claims description 61
- 239000000017 hydrogel Substances 0.000 claims description 45
- 239000011230 binding agent Substances 0.000 claims description 44
- 239000000203 mixture Substances 0.000 claims description 38
- 229920000615 alginic acid Polymers 0.000 claims description 34
- 235000010443 alginic acid Nutrition 0.000 claims description 34
- 239000012620 biological material Substances 0.000 claims description 34
- 238000000034 method Methods 0.000 claims description 30
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 19
- 229940072056 alginate Drugs 0.000 claims description 19
- 239000003795 chemical substances by application Substances 0.000 claims description 16
- 239000000783 alginic acid Substances 0.000 claims description 15
- 229960001126 alginic acid Drugs 0.000 claims description 15
- 150000004781 alginic acids Chemical class 0.000 claims description 15
- 101001063456 Homo sapiens Leucine-rich repeat-containing G-protein coupled receptor 5 Proteins 0.000 claims description 12
- 102100031036 Leucine-rich repeat-containing G-protein coupled receptor 5 Human genes 0.000 claims description 12
- 239000002202 Polyethylene glycol Substances 0.000 claims description 10
- 210000004027 cell Anatomy 0.000 claims description 10
- 229920001223 polyethylene glycol Polymers 0.000 claims description 10
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 8
- 102000004169 proteins and genes Human genes 0.000 claims description 8
- 108090000623 proteins and genes Proteins 0.000 claims description 8
- 210000000130 stem cell Anatomy 0.000 claims description 7
- -1 CD31 Proteins 0.000 claims description 6
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 claims description 6
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 claims description 6
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 claims description 6
- 101000884271 Homo sapiens Signal transducer CD24 Proteins 0.000 claims description 6
- 101000851007 Homo sapiens Vascular endothelial growth factor receptor 2 Proteins 0.000 claims description 6
- 108010021625 Immunoglobulin Fragments Proteins 0.000 claims description 6
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims description 6
- 102100024616 Platelet endothelial cell adhesion molecule Human genes 0.000 claims description 6
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 claims description 6
- 102100038081 Signal transducer CD24 Human genes 0.000 claims description 6
- 102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 claims description 6
- 150000003384 small molecules Chemical class 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 5
- 230000003472 neutralizing effect Effects 0.000 claims description 5
- 239000002738 chelating agent Substances 0.000 claims description 4
- 239000012530 fluid Substances 0.000 claims description 4
- 102000039446 nucleic acids Human genes 0.000 claims description 4
- 108020004707 nucleic acids Proteins 0.000 claims description 4
- 150000007523 nucleic acids Chemical class 0.000 claims description 4
- 239000000816 peptidomimetic Substances 0.000 claims description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical group OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 2
- 102000004190 Enzymes Human genes 0.000 claims description 2
- 108090000790 Enzymes Proteins 0.000 claims description 2
- 206010028980 Neoplasm Diseases 0.000 claims description 2
- 210000004504 adult stem cell Anatomy 0.000 claims description 2
- 201000011510 cancer Diseases 0.000 claims description 2
- 230000003511 endothelial effect Effects 0.000 claims description 2
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 claims description 2
- 239000001963 growth medium Substances 0.000 claims description 2
- 210000003958 hematopoietic stem cell Anatomy 0.000 claims description 2
- 210000004966 intestinal stem cell Anatomy 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 210000001178 neural stem cell Anatomy 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims description 2
- 230000002093 peripheral effect Effects 0.000 claims description 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 2
- 239000001509 sodium citrate Substances 0.000 claims description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 2
- 239000000758 substrate Substances 0.000 claims description 2
- 239000013077 target material Substances 0.000 claims description 2
- 150000001768 cations Chemical class 0.000 claims 6
- 230000015572 biosynthetic process Effects 0.000 claims 3
- 210000002889 endothelial cell Anatomy 0.000 claims 1
- 210000003491 skin Anatomy 0.000 claims 1
- 210000004881 tumor cell Anatomy 0.000 claims 1
- 208000005443 Circulating Neoplastic Cells Diseases 0.000 description 1
- 210000003663 amniotic stem cell Anatomy 0.000 description 1
- 210000002358 circulating endothelial cell Anatomy 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 210000000604 fetal stem cell Anatomy 0.000 description 1
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229920005596 polymer binder Polymers 0.000 description 1
- 239000002491 polymer binding agent Substances 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161439166P | 2011-02-03 | 2011-02-03 | |
| US61/439,166 | 2011-02-03 | ||
| PCT/US2012/023859 WO2012106658A1 (en) | 2011-02-03 | 2012-02-03 | Methods and compositions for highly specific capture and release of biological materials |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016238320A Division JP2017077245A (ja) | 2011-02-03 | 2016-12-08 | 生物学的材料の極めて特異的な捕獲および遊離のための方法および組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014506671A JP2014506671A (ja) | 2014-03-17 |
| JP2014506671A5 true JP2014506671A5 (https=) | 2015-03-26 |
| JP6120778B2 JP6120778B2 (ja) | 2017-04-26 |
Family
ID=46603107
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013552696A Active JP6120778B2 (ja) | 2011-02-03 | 2012-02-03 | 生物学的材料の極めて特異的な捕獲および遊離のための方法および組成物 |
| JP2016238320A Abandoned JP2017077245A (ja) | 2011-02-03 | 2016-12-08 | 生物学的材料の極めて特異的な捕獲および遊離のための方法および組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016238320A Abandoned JP2017077245A (ja) | 2011-02-03 | 2016-12-08 | 生物学的材料の極めて特異的な捕獲および遊離のための方法および組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9927334B2 (https=) |
| EP (1) | EP2670856B1 (https=) |
| JP (2) | JP6120778B2 (https=) |
| KR (1) | KR101922741B1 (https=) |
| ES (1) | ES2687144T3 (https=) |
| SG (2) | SG10201600803SA (https=) |
| WO (1) | WO2012106658A1 (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014072465A1 (en) | 2012-11-09 | 2014-05-15 | Roche Diagnostics Gmbh | In vitro capture and analysis of circulating tumor cells |
| EP2951585B1 (en) | 2013-02-01 | 2018-01-03 | The General Hospital Corporation | Capture and release of particles from liquid samples |
| US20170074870A1 (en) | 2014-03-14 | 2017-03-16 | Northeastern University | Microfluidic System and Method for Real-Time Measurement of Antibody-Antigen Binding and Analyte Detection |
| WO2015148512A1 (en) | 2014-03-24 | 2015-10-01 | Qt Holdings Corp | Shaped articles including hydrogels and methods of manufacture and use thereof |
| US11583860B2 (en) * | 2014-12-22 | 2023-02-21 | Ecole Polytechnique Federale De Lausanne (Epfl) | Microstructured thin hydrogel films |
| US9790467B2 (en) | 2015-09-22 | 2017-10-17 | Qt Holdings Corp | Methods and compositions for activation or expansion of T lymphocytes |
| EP3378945B1 (en) * | 2015-12-14 | 2021-04-28 | Quanta Matrix Co., Ltd. | Method for distinguishing particular cells from mixture of heterogeneous cells |
| CN109154614B (zh) * | 2016-03-18 | 2022-01-28 | 四方控股公司 | 用于细胞分离的组合物、装置和方法 |
| US10429387B2 (en) * | 2016-07-27 | 2019-10-01 | Universiteit Tweate | Simple and affordable method for immuophenotyping using a microfluidic chip sample preparation with image cytometry |
| US11118163B2 (en) | 2017-02-02 | 2021-09-14 | Sartorius Stedim Biotech Gmbh | Separation of cell populations by marker identification and sedimentation velocity |
| DE102017105195A1 (de) | 2017-03-10 | 2018-09-13 | Leibniz-Institut Für Polymerforschung Dresden E.V. | Verfahren zur differenzierten Sequestrierung von Stoffen verschiedener Stoffgruppen mit Hilfe von sulfatierte oder sulfonierte Komponenten enthaltenden Hydrogelen |
| KR20190138646A (ko) * | 2017-03-20 | 2019-12-13 | 큐티 홀딩스 코포레이션 | 면역 세포의 조절을 위한 방법 및 조성물 |
| WO2019239359A2 (en) | 2018-06-13 | 2019-12-19 | University Of Washington | Extruded hydrogel tubes and coaxial fibers and applications thereof |
| EP3626814B1 (en) * | 2018-09-21 | 2023-03-08 | Technische Universität Wien | Production of cellular spheroids |
| JP7120547B2 (ja) * | 2019-02-22 | 2022-08-17 | 国立研究開発法人理化学研究所 | 物質固定化剤、及び当該物質固定化剤を用いた物質固定化方法 |
| US11976269B2 (en) * | 2019-03-18 | 2024-05-07 | Cellular Research, Inc. | Precise delivery of components into fluids |
| US11668676B2 (en) * | 2019-05-30 | 2023-06-06 | The Regents Of The University Of California | Microfluidic acoustic devices and methods |
| CN112708150B (zh) * | 2020-12-08 | 2021-11-16 | 济南国科医工科技发展有限公司 | 用于循环肿瘤细胞的捕获及定点释放的水凝胶体系 |
| WO2023034430A1 (en) | 2021-09-01 | 2023-03-09 | Bio-Techne Corporation | Human vitronectin fragments and uses thereof |
| US11805995B1 (en) | 2022-11-22 | 2023-11-07 | King Faisal University | Saliva collection kit |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2266581C (en) * | 1996-09-19 | 2007-03-13 | The Regents Of The University Of Michigan | Polymers containing polysaccharides such as alginates or modified alginates |
| CA2466116C (en) * | 2001-11-07 | 2012-04-24 | Eidgenossisch Technische Hochschule Zurich | Synthetic matrix for controlled cell ingrowth and tissue regeneration |
| MXPA04006021A (es) * | 2001-12-18 | 2005-08-19 | Eth Zuerich | Matrices de proteina modificada con factor de crecimiento para ingenieria de tejidos. |
| AU2003248273A1 (en) * | 2002-07-12 | 2004-02-02 | Mitsubishi Chemical Corporation | Analytical chip, analytical chip unit, analyzing apparatus, method of analysis using the apparatus, and method of producing the analytical chip |
| CA2500392C (en) | 2002-09-27 | 2012-11-27 | The General Hospital Corporation | Microfluidic device for cell separation and uses thereof |
| EP2946666B1 (en) * | 2004-04-30 | 2017-11-15 | OrbusNeich Medical, Inc. | Medical device with coating for capturing genetically-altered cells and methods of using same |
| SE0402476D0 (sv) * | 2004-10-13 | 2004-10-13 | Biacore Ab | Preparation and use of a reactive solid support surface |
| CN101338036B (zh) | 2007-07-06 | 2010-11-03 | 常州百瑞吉生物医药有限公司 | 生物相容快速凝胶化水凝胶及其喷雾剂的制备方法 |
| JP2011505802A (ja) | 2007-12-10 | 2011-03-03 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | パターニングされた細胞シート及びその製造方法 |
| US20120077246A1 (en) * | 2009-04-24 | 2012-03-29 | The Board Of Trustees Of The University Of Illinoi | Methods and Devices for Capturing Circulating Tumor Cells |
| US20140154703A1 (en) * | 2011-01-06 | 2014-06-05 | Alison Skelley | Circulating tumor cell capture on a microfluidic chip incorporating both affinity and size |
-
2012
- 2012-02-03 ES ES12742728.4T patent/ES2687144T3/es active Active
- 2012-02-03 JP JP2013552696A patent/JP6120778B2/ja active Active
- 2012-02-03 US US13/982,680 patent/US9927334B2/en active Active
- 2012-02-03 SG SG10201600803SA patent/SG10201600803SA/en unknown
- 2012-02-03 KR KR1020137023006A patent/KR101922741B1/ko active Active
- 2012-02-03 EP EP12742728.4A patent/EP2670856B1/en active Active
- 2012-02-03 WO PCT/US2012/023859 patent/WO2012106658A1/en not_active Ceased
- 2012-02-03 SG SG2013058797A patent/SG192587A1/en unknown
-
2016
- 2016-12-08 JP JP2016238320A patent/JP2017077245A/ja not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014506671A5 (https=) | ||
| Oh et al. | Wide-range stiffness gradient PVA/HA hydrogel to investigate stem cell differentiation behavior | |
| Chen et al. | Sensitive and specific biomimetic lipid coated microfluidics to isolate viable circulating tumor cells and microemboli for cancer detection | |
| Kuhn et al. | Regulation of stemness and stem cell niche of mesenchymal stem cells: implications in tumorigenesis and metastasis | |
| Singh et al. | Proliferation of myoblast skeletal cells on three-dimensional supermacroporous cryogels | |
| Debnath et al. | Proliferation and differentiation potential of human adipose-derived stem cells grown on chitosan hydrogel | |
| Li et al. | Endonuclease-responsive aptamer-functionalized hydrogel coating for sequential catch and release of cancer cells | |
| Ratajczak et al. | Very small embryonic/epiblast-like stem cells (VSELs) and their potential role in aging and organ rejuvenation–an update and comparison to other primitive small stem cells isolated from adult tissues | |
| EP3219790B1 (en) | Myocardial cell sheet | |
| US10739338B2 (en) | Shaped articles including hydrogels and methods of manufacture and use thereof | |
| Gorkun et al. | Angiogenic potential of spheroids from umbilical cord and adipose-derived multipotent mesenchymal stromal cells within fibrin gel | |
| JP2013255517A5 (https=) | ||
| ATE476505T1 (de) | Verfahren zur isolierung von nukleinsäuren mit verwendung von ethylenglykol-multimeren | |
| Andree et al. | Capture of tumor cells on anti-EpCAM-functionalized poly (acrylic acid)-coated surfaces | |
| Ullah et al. | Mesenchymal stem cells and their chondrogenic differentiated and dedifferentiated progeny express chemokine receptor CCR9 and chemotactically migrate toward CCL25 or serum | |
| JP2018505691A (ja) | 細胞を評価するためのデバイス、プラットフォームおよびアッセイ | |
| Sasse et al. | Angiogenic potential of bone marrow derived CD133+ and CD271+ intramyocardial stem cell trans-plantation post MI | |
| WO2013056090A1 (en) | Affinity-based materials for the non-destructive separation and recovery of cells | |
| Frankman et al. | Application of microfluidic systems for breast cancer research | |
| Heo et al. | LIGHT (TNFSF14) increases the survival and proliferation of human bone marrow-derived mesenchymal stem cells | |
| Karnas et al. | Extracellular vesicles from human iPSCs enhance reconstitution capacity of cord blood-derived hematopoietic stem and progenitor cells | |
| Pfaff et al. | Microporous annealed particle (MAP) scaffold pore size influences mesenchymal stem cell metabolism and proliferation without changing CD73, CD90, and CD105 expression over two weeks | |
| JP2022546253A (ja) | 細胞外マトリクスの調節 | |
| Liu et al. | Ovarian cancer stem-like cells with induced translineage-differentiation capacity and are suppressed by alkaline phosphatase inhibitor | |
| Maerz et al. | Bone marrow-derived mesenchymal stromal cells differ in their attachment to fibronectin-derived peptides from term placenta-derived mesenchymal stromal cells |